Author:
Strupp C,Hildebrandt B,Germing U,Haas R,Gattermann N
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference8 articles.
1. Strupp C, Germing U, Aivado M, Misgeld E, Haas R, Gattermann N . Thalidomide for the treatment of patients with myelodysplastic syndromes. Leukemia 2002; 16: 1–6.
2. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088.
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189–199.
4. Cheson BD, Bennett JM, Kantarjian H, Pinto A, Schiffer CA, Nimer SD et al. Report of an international working group standardize response criteria for myelodysplastic syndromes. Blood 2000; 96: 3671–3674.
5. Canepa L, Ballerini F, Varaldo R, Quintino S, Reni L, Clavio M et al. Thalidomide in agnogenic and secondary myelofibrosis. Br J Haematol 2001; 115: 313–315.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献